Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia. [electronic resource]
Producer: 20140610Description: 2169-78 p. digitalISSN:- 1476-5594
- Animals
- Antineoplastic Agents -- pharmacology
- Asparaginase -- pharmacology
- Bridged Bicyclo Compounds, Heterocyclic -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Dexamethasone -- pharmacology
- Down-Regulation -- drug effects
- Drug Resistance, Neoplasm
- Drug Synergism
- Humans
- Inhibitor of Apoptosis Proteins -- genetics
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Mutation
- Peptide Fragments -- antagonists & inhibitors
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Pyrimidinones -- pharmacology
- Sialoglycoproteins -- antagonists & inhibitors
- Survivin
- Vincristine -- pharmacology
- Wnt Signaling Pathway
- Xenograft Model Antitumor Assays
- beta Catenin -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.